Treatment · June 23, 2026
Targeted Cancer Pill Gleevec Still Saving Lives 25 Years After Approval
A patient given just three years to live in 1998 has thrived for over two decades, offering hope to others....
Treatment · June 3, 2026
Targeted Cancer Drugs Help More Patients Live Longer With Disease
More cancer patients are living longer as targeted drug therapies continue to improve survival rates....
Cancer · June 1, 2026
Targeted Drug Doubles Survival in Metastatic Pancreatic Cancer Trial
Daraxonrasib represents a significant new treatment option that could improve outcomes for pancreatic cancer patients....
Cancer · May 31, 2026
New Bladder Cancer Drug Offers Hope After Standard Treatment Fails
New bladder cancer drug helps individual patient achieve improved outcomes and quality of life....
Treatment · May 27, 2026
China Accepts New Lung Cancer Drug for Priority Review in First-Line Treatment
A new targeted cancer therapy receives priority review status, accelerating its path to patients in need....
Breakthrough · May 11, 2026
FDA Expands Access to Targeted Drug That Shuts Down Pancreatic Cancer Growth
A targeted KRAS drug provides new therapeutic hope for pancreatic cancer patients....
Technology · April 22, 2026
New Diagnostic Test Expands Access to First Immunotherapy for Resistant Ovarian Cancer
New diagnostic test helps identify ovarian cancer patients who will benefit most from targeted immunotherapy treatment....
Cancer · April 21, 2026
New Generation of KRAS Drugs Offers Hope for Pancreatic and Other Cancers
Scientists develop a promising breakthrough drug targeting KRAS mutations in pancreatic cancer, offering hope for patients with th...
Treatment · April 17, 2026
Scientists Target Hijacked Growth System in Potential Liver and Bowel Cancer Treatment
Scientists discover a potential new cancer treatment, offering fresh therapeutic possibilities....
Cancer · April 13, 2026
Pancreatic Cancer Pill Nearly Doubles Survival in Pivotal Trial
Revolution Medicines' late-stage trial success brings potential breakthrough pancreatic cancer treatment closer to patients....
Cancer · April 10, 2026
New Therapies and Rising Youth Cases Highlight Gastrointestinal Cancer Symposium
A symposium showcases significant progress in gastrointestinal cancer treatment options and research initiatives....
Cancer · March 31, 2026
Researchers Identify Key Protein That Fuels Pancreatic Cancer Growth
Identification of pancreatic cancer's vulnerability opens promising new avenues for developing more effective treatments....
Cancer · March 29, 2026
New Targeted Therapy and Surgical Advances Improve Outlook for Colorectal Cancer Patients
Memorial Sloan Kettering's new colorectal cancer treatments aim to significantly reduce mortality rates in the coming years....
Cancer · March 25, 2026
First Targeted Therapy Approved for Debilitating Rare Blood Disorder
The first FDA-approved treatment for a rare blood cancer marks a major milestone in addressing a previously untreatable disease....
Cancer · March 24, 2026
New Breast Cancer Research Highlights Targeted Therapies and Patient Care Advances
Yale researchers present breakthrough breast cancer findings at international conference....
Cancer · March 23, 2026
New Targeted Therapy Approved for Advanced Gastric Cancer in China
Disitamab vedotin approval marks progress in expanding cancer treatment options for patients....
Cancer · March 19, 2026
New Cancer Drug Halts Tumor Growth by Isolating Key Gene Mutation
A groundbreaking cancer therapy stops tumor growth while preserving healthy cells, representing a major advance in treatment safet...
Cancer · January 18, 2026
New Oral Therapies Lead Major Advances In Breast Cancer Treatment
Five breakthrough areas in breast cancer research from 2025 demonstrate meaningful progress in understanding and treating the dise...
Cancer · January 8, 2026
Personalized Cancer Drug Regimens Show Significant Improvement in Treatment Success
Personalized cancer treatment approaches demonstrate significantly improved patient outcomes....